Premium
O157 EFFICACY OF A SECOND GENERATION THERMAL BALLOON DEVICE (THERMABLATE) FOR ENDOMETRIAL ABLATION IN THE TREATMENT OF ANEMIA INDUCED BY MENO/METRORRHAGIA
Author(s) -
D'Afiero A.,
Tommaselli G.A.,
Affinito P.,
Forleo F.,
Stanco D.
Publication year - 2012
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/s0020-7292(12)60587-6
Subject(s) - metrorrhagia , medicine , endometrial ablation , citation , gynecology , library science , surgery , hysterectomy , family planning , research methodology , computer science , population , environmental health
posterior: 25.3±14.2 vs. 39.4±11.3 mins). Global P-QoL domain scores significantly declined in both groups 6 months after surgery (Prolift group: 385±95 vs. 110±56; p < 0.01; Prosima group: 315±88 vs. 89±65; p < 0.01). Overall severity of prolapse symptom scores significantly declined in both groups, but no statistical difference was observed between them. Mean PGI-I score was 1 [range 1–5] in both groups. PISQ-12 and PGI-S scores were significantly reduced in both groups. Wexner constipation score was reduced only in patients undergone posterior repair. Overall anatomic cure rates were 89.5% for Prolift and 81.6% for Prosima (p NS). Complication (10.5% vs. 5.3%, p < 0.05) and dyspareunia rates were significantly higher in the Prolift group. Conclusions: Both devices were effective. QoL scores did not significantly differ between the two groups, but tended to be lower in the Prosima group. Complications and de novo dyspareunia were higher in the Prolift group.